Korea Republic Of to India: Pembrolizumab Import Trade Route
India has recorded 1 verified shipments of Pembrolizumab imported from Korea Republic Of, representing a combined trade value of $39.7K USD. This corridor is served by 1 active Korea Republic Of exporters, with an average shipment value of $39.7K USD. The leading Korea Republic Of supplier is NUVISAN FRANCE SARL, which accounts for 100% of total import value with 1 shipments worth $39.7K USD. On the buying side, FORTREA DEVELOPMENT INDIA PRIVATE LIMITED is the largest Indian importer with $39.7K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill of entry records. Values reported in FOB USD.
Route Intelligence Overview
The Korea Republic Of to India Pembrolizumab corridor is one of India's established pharmaceutical import routes from Korea Republic Of, with 1 shipments documented worth a combined $39.7K USD. The route is dominated by NUVISAN FRANCE SARL, which alone accounts for roughly 100% of all import value, reflecting the consolidated nature of Korea Republic Of's pembrolizumab export sector.
Across 1 active Korea Republic Of suppliers, the average shipment value stands at $39.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 78% of all shipments, consistent with pembrolizumab's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 27 days port-to-port. The route has recorded an annual growth rate of 29.3%, placing it at rank #18 among India's top pembrolizumab import origins globally.
On the Indian buyer side, key Indian importers include FORTREA DEVELOPMENT INDIA PRIVATE LIMITED. FORTREA DEVELOPMENT INDIA PRIVATE LIMITED is the single largest Indian importer with 1 shipments valued at $39.7K USD.
Route Characteristics
- Average transit27 days
- Peak seasonQ3
- Primary modeSea freight
- Top port of entryBombay Air Cargo
Market Position
- Global rank#18
- Annual growth+29.3%
- Demand growth+26.4%
- Regulatory ease82/100
Top 10 Pembrolizumab Exporters from Korea Republic Of to India
Showing top 10 of 1 Korea Republic Of suppliers exporting Pembrolizumab to India, ranked by total trade value (USD)
| Rank | Supplier (Korea Republic Of Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | NUVISAN FRANCE SARL Avg $39.7K per shipment | 1 | $39.7K | 100.0% |
This table shows the top 10 of 1 Korea Republic Of companies exporting pembrolizumab to India, ranked by total trade value. The listed exporters are: NUVISAN FRANCE SARL. NUVISAN FRANCE SARL is the dominant supplier with 1 shipments worth $39.7K USD, giving it a 100% market share.
Top 10 Indian Pembrolizumab Importers from Korea Republic Of
Showing top 10 of 1 known Indian buyers receiving Pembrolizumab shipments from Korea Republic Of, ranked by import value
On the receiving end of this trade route, the leading Indian importers of Korea Republic Of pembrolizumab include FORTREA DEVELOPMENT INDIA PRIVATE LIMITED. The largest importer is FORTREA DEVELOPMENT INDIA PRIVATE LIMITED, accounting for $39.7K USD across 1 shipments — representing 100% of all pembrolizumab imports from Korea Republic Of on this route.
| Rank | Indian Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | FORTREA DEVELOPMENT INDIA PRIVATE LIMITED | 1 | $39.7K | 100.0% |
Top 10 Pembrolizumab Formulations Imported from Korea Republic Of
Showing top 10 of 1 product formulations shipped on the Korea Republic Of to India Pembrolizumab route, ranked by trade value
India imports a wide range of pembrolizumab formulations from Korea Republic Of, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — FOC IMPORT FOR CLINICAL TRIAL USE PEMBROLIZUMAB SB27 OR KEYTRUDA 100 MG 4ML 25 MG ML IMPORT FOR CLINICAL TRIAL USE — accounts for $39.7K USD across 1 shipments. A total of 1 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | FOC IMPORT FOR CLINICAL TRIAL USE PEMBROLIZUMAB SB27 OR KEYTRUDA 100 MG 4ML 25 MG ML IMPORT FOR CLINICAL TRIAL USE | 1 | $39.7K | 100.0% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 78%, typical for bulk pharmaceutical shipments.
Top Indian Ports of Entry
Bombay Air Cargo handles the highest volume with 1 shipments. Transit time averages 27 days by sea.
Market Dynamics
India's pembrolizumab imports from Korea Republic Of are driven primarily by a handful of large-scale Korea Republic Of manufacturers. NUVISAN FRANCE SARL with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — Indian buyers benefit from Korea Republic Of supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — NUVISAN FRANCE SARL — together account for 100% of total trade value on this route. The average shipment value of $39.7K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
On the buying side, FORTREA DEVELOPMENT INDIA PRIVATE LIMITED is the largest importer with 1 shipments worth $39.7K USD — representing 100% of all pembrolizumab imports from Korea Republic Of on this route.
Route Statistics
- Trade Volume
- $39.7K
- Avg. Shipment
- $39.7K
- Suppliers
- 1
- Buyers
- 1
- Transit (Sea)
- ~27 days
- Annual Growth
- +29.3%
Related Analysis
Other Pembrolizumab Routes
Unlock the Full Korea Republic Of to India Pembrolizumab Dataset
TransData Nexus provides verified shipment-level records, exporter contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 1 shipments on this route.
Frequently Asked Questions — Korea Republic Of to India Pembrolizumab Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Korea Republic Of companies export Pembrolizumab to India?
The leading Korea Republic Of exporters of Pembrolizumab to India are NUVISAN FRANCE SARL. NUVISAN FRANCE SARL holds the largest market share at approximately 100% of total trade value on this route.
Q What is the total value of Pembrolizumab imports from Korea Republic Of to India?
India imports Pembrolizumab from Korea Republic Of worth approximately $39.7K USD across 1 recorded shipments. The average value per shipment is $39.7K USD.
Q Which Indian ports receive Pembrolizumab from Korea Republic Of?
The most active Indian port of entry is Bombay Air Cargo with 1 shipments. Korea Republic Of exporters primarily use sea freight for this route, with 78% of shipments going by sea and 25% by air.
Q How long does shipping take from Korea Republic Of to India for Pembrolizumab?
The average transit time for Pembrolizumab shipments from Korea Republic Of to India is approximately 27 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the Korea Republic Of to India Pembrolizumab import route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 29.3% with demand growth tracking at 26.4%. The route is ranked #18 among India's top Pembrolizumab import origins globally.
Q How many Korea Republic Of suppliers are active on this Pembrolizumab import route?
There are currently 1 active Korea Republic Of suppliers exporting Pembrolizumab to India. The market is moderately concentrated with NUVISAN FRANCE SARL accounting for 100% of total shipment value.
Q Who are the main Indian importers of Pembrolizumab from Korea Republic Of?
The leading Indian importers of Pembrolizumab from Korea Republic Of include FORTREA DEVELOPMENT INDIA PRIVATE LIMITED. FORTREA DEVELOPMENT INDIA PRIVATE LIMITED is the largest buyer with 1 shipments worth $39.7K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Korea Republic Of export trade corridor identified from Indian Customs (DGFT) records for Pembrolizumab.
- 2.Supplier/Buyer Matching: 1 Indian exporters and 1 importers in Korea Republic Of matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 1 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1 Verified Shipments
1 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists